In one study, T cell lines derived from MS patients and activated with PLP showed the strongest reactivity against regions 40–60, 95–117, 117–150, and 185–206 out of all 9 regions of PLP tested20. The gene discussed is PLP1; the disease is myeloid sarcoma.